Please note that this event is already in progress or has finished.
It might be possible to obtain information from the organiser about similar future events [or if available notes/abstract from this meeting]. Please use the "INQUIRE" button below.
Go to current meetings
Date: 5th - 6th June, 2008
Location: Copenhagen, Denmark
Summary:Pharmaceutical - Seminar
Learning Goals Environmental monitoring is one of the systems that decide about the product quality in the manufacture of sterile medicinal products. Both European and American GMP regulations place special focus on this topic.
The USP 1116 and especially the FDA's "Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing -Current Good Manufacturing Practice" deal in detail with environmental monitoring.
However, many of the requirements laid down in these documents seem to be excessive for everyday practice on the one hand and leave great scope for interpretation on the other hand.
The lectures and workshops of this Education Course present the following aspects in detail:
- Current regulations
- Non-viable (particulate) air monitoring
- Establishment of an environmental monitoring programme
- Isolator monitoring
- Air monitoring
- Surface / personnel monitoring
- Environmental Monitoring during Media Fills
- Microbiological methods
- Interpretation of OOS results
- Investigation / documentation / trending
As there is often a lack of detailed requirements, in practice, environmental monitoring programmes sometimes develop into time-consuming, cost- and personnel-intensive measures. Therefore, it is the aim of this course to provide the participants with pragmatic recommendations for the creation and implementation of environmental monitoring programmes.
Within the framework of this course, the participants are confronted with current hot topics, like:
Alert / action levels
Relationship to batch release
Locations and frequency
Identification of isolates
Sampling procedures
and get to know solutions for their own company practice.
